Dongsheng Biotech (Taixing) Co., Ltd.

Dongsheng Biotech (Taixing) Co., Ltd., established in 2007, is a global leader in the research, development, and production of Transglutaminase (TG enzyme) and Curdlan. The company operates from a state-of-the-art facility spanning over 150,000 square meters in Taixing, Jiangsu, China, and employs over 200 professionals. Dongsheng Biotech is renowned for its innovative approach, having established a dedicated R&D center in Shanghai in 2011. The company collaborates with prestigious institutions such as Shanghai Jiaotong University and East China Normal University to advance the development of green and healthy food additives. Its flagship products, TG enzyme and Curdlan, are widely recognized for their quality and efficacy, serving industries ranging from food processing to biotechnology. With a strong global presence, Dongsheng Biotech exports its products to numerous countries and maintains partnerships with leading academic and industrial organizations. The company is committed to sustainability and innovation, aiming to contribute to the future of food through cutting-edge technology and research.

The Nombase Funding database has 4,288 records from over 1,788 companies.

There's no funding data for this company.